Congestive Heart Failure (Heart Failure) Global Clinical Trials Review, H1, 2013

• Publication date: February 2013
• Report size: 115 pages

Congestive Heart Failure (Heart Failure) Global Clinical Trials Review, H1, 2013 Summary GlobalData's clinical trial report, “Congestive Heart Failure (Heart Failure) Global Clinical Trials Review, H1, 2013" provides data on the Congestive Heart Failure (Heart Failure) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Congestive Heart Failure (Hea...

Congestive Heart Failure (Heart Failure) Global Clinical Trials Review, H1, 2013



Summary



GlobalData's clinical trial report, “Congestive Heart Failure (Heart Failure) Global Clinical Trials Review, H1, 2013" provides data on the Congestive Heart Failure (Heart Failure) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Congestive Heart Failure (Heart Failure). It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Congestive Heart Failure (Heart Failure). This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.



Scope


- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)



Reasons to buy


- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Global Pathology Industry

Table of Contents
Table of Contents 2
List of Tables 5
List of Figures 7
Introduction 8
Congestive Heart Failure (Heart Failure) 8
Report Guidance 8
Clinical Trials by Region 9
Clinical Trials by Country 10
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 12
Top Five Countries Contributing to Clinical Trials in Europe 13
Top Countries Contributing to Clinical Trials in North America 14
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 15
Top Five Countries Contributing to Clinical Trials in Central and South America 16
Clinical Trials by BRIC Nations 17
Clinical Trials by G7 Nations 18
Clinical Trials in G7 Nations by Trial Status 19
Clinical Trials by E7 Nations 20
Clinical Trials in E7 Nations by Trial Status 21
Clinical Trials by Phase 22
In Progress Trials by Phase 23
Clinical Trials by Trial Status 24
Unaccomplished Trials of Congestive Heart Failure (Heart Failure) 25
Subjects Recruited Over a Period of Time 37
Prominent Sponsors 38
Top Companies Participating in Congestive Heart Failure (Heart Failure) Therapeutics Clinical Trials 40
Prominent Drug Comparison 42
Clinical Trial Profiles 43
Clinical Trial Overview of Top Companies 43
Novartis AG 43
Clinical Trial Overview of Novartis AG 43
AstraZeneca PLC 45
Clinical Trial Overview of AstraZeneca PLC 45
Scios Inc. 46
Clinical Trial Overview of Scios Inc. 46
Amgen Inc. 48
Clinical Trial Overview of Amgen Inc. 48
Bayer AG 49
Clinical Trial Overview of Bayer AG 49
Medtronic, Inc. 50
Clinical Trial Overview of Medtronic, Inc. 50
Otsuka Pharmaceutical Co., Ltd. 51
Clinical Trial Overview of Otsuka Pharmaceutical Co., Ltd. 51
Pfizer Inc. 52
Clinical Trial Overview of Pfizer Inc. 52
GlaxoSmithKline plc 53
Clinical Trial Overview of GlaxoSmithKline plc 53
Zensun (Shanghai) Sci. &Tech. Co., Ltd. 54
Clinical Trial Overview of Zensun (Shanghai) Sci. &Tech. Co., Ltd. 54
St. Jude Medical, Inc. 55
Clinical Trial Overview of St. Jude Medical, Inc. 55
GE Healthcare 56
Clinical Trial Overview of GE Healthcare 56
Nile Therapeutics, Inc. 57
Clinical Trial Overview of Nile Therapeutics, Inc. 57
Cytokinetics, Incorporated 58
Clinical Trial Overview of Cytokinetics, Incorporated 58
NovaCardia, Inc. 59
Clinical Trial Overview of NovaCardia, Inc. 59
Bioheart, Inc. 60
Clinical Trial Overview of Bioheart, Inc. 60
Zambon Company S.p.A. 61
Clinical Trial Overview of Zambon Company S.p.A. 61
Sanofi 62
Clinical Trial Overview of Sanofi 62
Johnson & Johnson 63
Clinical Trial Overview of Johnson & Johnson 63
Boston Scientific Corporation 64
Clinical Trial Overview of Boston Scientific Corporation 64
Clinical Trial Overview of Top Universities / Institutes / Hospitals 65
Mayo Clinic 65
Clinical Trial Overview of Mayo Clinic 65
Duke University 67
Clinical Trial Overview of Duke University 67
Massachusetts General Hospital 68
Clinical Trial Overview of Massachusetts General Hospital 68
Emory University 69
Clinical Trial Overview of Emory University 69
University Medical Center Groningen 70
Clinical Trial Overview of University Medical Center Groningen 70
University of Michigan 71
Clinical Trial Overview of University of Michigan 71
University of Alberta 72
Clinical Trial Overview of University of Alberta 72
The Alfred Hospital 73
Clinical Trial Overview of The Alfred Hospital 73
Assistance Publique - Hopitaux de Paris 74
Clinical Trial Overview of Assistance Publique - Hopitaux de Paris 74
Brigham and Women's Hospital 75
Clinical Trial Overview of Brigham and Women's Hospital 75
University of Wisconsin Madison 76
Clinical Trial Overview of University of Wisconsin Madison 76
The Ohio State University 77
Clinical Trial Overview of The Ohio State University 77
Aarhus University 78
Clinical Trial Overview of Aarhus University 78
The University of Utah 79
Clinical Trial Overview of The University of Utah 79
The Federico II University 80
Clinical Trial Overview of The Federico II University 80
Fuwai Heart Hospital & Cardiovascular Institute 81
Clinical Trial Overview of Fuwai Heart Hospital & Cardiovascular Institute 81
St. Michael's Hospital 82
Clinical Trial Overview of St. Michael's Hospital 82
Johann Wolfgang Goethe University Hospitals 83
Clinical Trial Overview of Johann Wolfgang Goethe University Hospitals 83
Norwegian University of Science and Technology 84
Clinical Trial Overview of Norwegian University of Science and Technology 84
University of Ottawa Heart Institute 85
Clinical Trial Overview of University of Ottawa Heart Institute 85
Five Key Clinical Profiles 86
Appendix 112
Abbreviations 112
Definitions 112
Research Methodology 113
Secondary Research 113
About GlobalData 114
Contact Us 114
Disclaimer 114
Source 115

List of Tables

Congestive Heart Failure (Heart Failure) Therapeutics Market, Global, Clinical Trials by Zone, 2013* 9
Congestive Heart Failure (Heart Failure) Therapeutics Market, Global, Clinical Trials by Top Countries, 2013* 10
Congestive Heart Failure (Heart Failure) Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2013* 11
Congestive Heart Failure (Heart Failure) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2013* 12
Congestive Heart Failure (Heart Failure) Therapeutics Clinical Trials, Europe, Top Five Countries, 2013* 13
Congestive Heart Failure (Heart Failure) Therapeutics Clinical Trials, North America, Top Countries, 2013* 14
Congestive Heart Failure (Heart Failure) Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2013* 15
Congestive Heart Failure (Heart Failure) Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2013* 16
Congestive Heart Failure (Heart Failure) Therapeutics Clinical Trials, BRIC Countries, 2013* 17
Congestive Heart Failure (Heart Failure) Therapeutics Clinical Trials, G7 Countries, 2013* 18
Congestive Heart Failure (Heart Failure) Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2013* 19
Congestive Heart Failure (Heart Failure) Therapeutics Clinical Trials, E7 Countries, 2013* 20
Congestive Heart Failure (Heart Failure) Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2013* 21
Congestive Heart Failure (Heart Failure) Therapeutics Market, Global, Clinical Trials by Phase, 2013* 22
Congestive Heart Failure (Heart Failure) Therapeutics Market, Global, Clinical Trials In Progress by Phase 2013* 23
Congestive Heart Failure (Heart Failure) Therapeutics Market, Global, Clinical Trials by Trial Status, 2013* 24
Congestive Heart Failure (Heart Failure) Therapeutics Market, Global, Suspended Clinical Trials, 2013* 25
Congestive Heart Failure (Heart Failure) Therapeutics Market, Global, Withdrawn Clinical Trials, 2013* 27
Congestive Heart Failure (Heart Failure) Therapeutics Market, Global, Terminated Clinical Trials, 2013* 29
Congestive Heart Failure (Heart Failure) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2007-2012 37
Congestive Heart Failure (Heart Failure) Therapeutics Clinical Trials, Global, Key Sponsors, 2013* 39
Congestive Heart Failure (Heart Failure) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2013* 41
Congestive Heart Failure (Heart Failure) Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2013* 42
Congestive Heart Failure (Heart Failure) Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2013* 43
Congestive Heart Failure (Heart Failure) Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2013* 45
Congestive Heart Failure (Heart Failure) Therapeutics Clinical Trials Market, Global, Clinical Trials by Scios Inc., 2013* 46
Congestive Heart Failure (Heart Failure) Therapeutics Clinical Trials Market, Global, Clinical Trials by Amgen Inc., 2013* 48
Congestive Heart Failure (Heart Failure) Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2013* 49
Congestive Heart Failure (Heart Failure) Therapeutics Clinical Trials Market, Global, Clinical Trials by Medtronic, Inc., 2013* 50
Congestive Heart Failure (Heart Failure) Therapeutics Clinical Trials Market, Global, Clinical Trials by Otsuka Pharmaceutical Co., Ltd., 2013* 51
Congestive Heart Failure (Heart Failure) Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2013* 52
Congestive Heart Failure (Heart Failure) Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2013* 53
Congestive Heart Failure (Heart Failure) Therapeutics Clinical Trials Market, Global, Clinical Trials by Zensun (Shanghai) Sci. &Tech. Co., Ltd., 2013* 54
Congestive Heart Failure (Heart Failure) Therapeutics Clinical Trials Market, Global, Clinical Trials by St. Jude Medical, Inc., 2013* 55
Congestive Heart Failure (Heart Failure) Therapeutics Clinical Trials Market, Global, Clinical Trials by GE Healthcare, 2013* 56
Congestive Heart Failure (Heart Failure) Therapeutics Clinical Trials Market, Global, Clinical Trials by Nile Therapeutics, Inc., 2013* 57
Congestive Heart Failure (Heart Failure) Therapeutics Clinical Trials Market, Global, Clinical Trials by Cytokinetics, Incorporated, 2013* 58
Congestive Heart Failure (Heart Failure) Therapeutics Clinical Trials Market, Global, Clinical Trials by NovaCardia, Inc., 2013* 59
Congestive Heart Failure (Heart Failure) Therapeutics Clinical Trials Market, Global, Clinical Trials by Bioheart, Inc., 2013* 60
Congestive Heart Failure (Heart Failure) Therapeutics Clinical Trials Market, Global, Clinical Trials by Zambon Company S.p.A., 2013* 61
Congestive Heart Failure (Heart Failure) Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2013* 62
Congestive Heart Failure (Heart Failure) Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson & Johnson, 2013* 63
Congestive Heart Failure (Heart Failure) Therapeutics Clinical Trials Market, Global, Clinical Trials by Boston Scientific Corporation, 2013* 64
Congestive Heart Failure (Heart Failure) Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic, 2013* 65
Congestive Heart Failure (Heart Failure) Therapeutics Clinical Trials Market, Global, Clinical Trials by Duke University, 2013* 67
Congestive Heart Failure (Heart Failure) Therapeutics Clinical Trials Market, Global, Clinical Trials by Massachusetts General Hospital, 2013* 68
Congestive Heart Failure (Heart Failure) Therapeutics Clinical Trials Market, Global, Clinical Trials by Emory University, 2013* 69
Congestive Heart Failure (Heart Failure) Therapeutics Clinical Trials Market, Global, Clinical Trials by University Medical Center Groningen, 2013* 70
Congestive Heart Failure (Heart Failure) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Michigan, 2013* 71
Congestive Heart Failure (Heart Failure) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Alberta, 2013* 72
Congestive Heart Failure (Heart Failure) Therapeutics Clinical Trials Market, Global, Clinical Trials by The Alfred Hospital, 2013* 73
Congestive Heart Failure (Heart Failure) Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique - Hopitaux de Paris, 2013* 74
Congestive Heart Failure (Heart Failure) Therapeutics Clinical Trials Market, Global, Clinical Trials by Brigham and Women's Hospital, 2013* 75
Congestive Heart Failure (Heart Failure) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Wisconsin Madison, 2013* 76
Congestive Heart Failure (Heart Failure) Therapeutics Clinical Trials Market, Global, Clinical Trials by The Ohio State University, 2013* 77
Congestive Heart Failure (Heart Failure) Therapeutics Clinical Trials Market, Global, Clinical Trials by Aarhus University, 2013* 78
Congestive Heart Failure (Heart Failure) Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Utah, 2013* 79
Congestive Heart Failure (Heart Failure) Therapeutics Clinical Trials Market, Global, Clinical Trials by The Federico II University, 2013* 80
Congestive Heart Failure (Heart Failure) Therapeutics Clinical Trials Market, Global, Clinical Trials by Fuwai Heart Hospital & Cardiovascular Institute, 2013* 81
Congestive Heart Failure (Heart Failure) Therapeutics Clinical Trials Market, Global, Clinical Trials by St. Michael's Hospital, 2013* 82
Congestive Heart Failure (Heart Failure) Therapeutics Clinical Trials Market, Global, Clinical Trials by Johann Wolfgang Goethe University Hospitals, 2013* 83
Congestive Heart Failure (Heart Failure) Therapeutics Clinical Trials Market, Global, Clinical Trials by Norwegian University of Science and Technology, 2013* 84
Congestive Heart Failure (Heart Failure) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Ottawa Heart Institute, 2013* 85

List of Figures

Congestive Heart Failure (Heart Failure) Therapeutics Market, Global, Clinical Trials by Zone (%), 2013* 9
Congestive Heart Failure (Heart Failure) Therapeutics Market, Global, Clinical Trials by Top Countries, 2013* 10
Congestive Heart Failure (Heart Failure) Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2013* 11
Congestive Heart Failure (Heart Failure) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2013* 12
Congestive Heart Failure (Heart Failure) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2013* 13
Congestive Heart Failure (Heart Failure) Therapeutics Clinical Trials, North America, Top Countries (%), 2013* 14
Congestive Heart Failure (Heart Failure) Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2013* 15
Congestive Heart Failure (Heart Failure) Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2013* 16
Congestive Heart Failure (Heart Failure) Therapeutics Clinical Trials, BRIC Countries (%), 2013* 17
Congestive Heart Failure (Heart Failure) Therapeutics Clinical Trials, G7 Countries (%), 2013* 18
Congestive Heart Failure (Heart Failure) Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2013* 19
Congestive Heart Failure (Heart Failure) Therapeutics Clinical Trials, E7 Countries (%), 2013* 20
Congestive Heart Failure (Heart Failure) Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2013* 21
Congestive Heart Failure (Heart Failure) Therapeutics Market, Global, Clinical Trials by Phase (%), 2013* 22
Congestive Heart Failure (Heart Failure) Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2013* 23
Congestive Heart Failure (Heart Failure) Therapeutics Market, Global, Clinical Trials by Trial Status, 2013* 24
Congestive Heart Failure (Heart Failure) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2007-2012 37
Congestive Heart Failure (Heart Failure) Therapeutics Clinical Trials, Global, Key Sponsors, 2013* 38
Congestive Heart Failure (Heart Failure) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2013* 40
Congestive Heart Failure (Heart Failure) Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2013* 42
GlobalData Methodology 113

Cardiovascular Disease in World

Fiji Rheumatic Heart Disease, Total, Male, Dalys

• $ 250
• Industry data
• May 2013

Yearly, From 2005 To 2030
By Business Monitor International
Source: WHO, World Bank, IMF, BMI research

• Industries : Pathology
• Countries : Fiji, World

Niue Rheumatic Heart Disease, Total, Male, Dalys

• $ 250
• Industry data
• May 2013

Yearly, From 2005 To 2030
By Business Monitor International
Source: WHO, World Bank, IMF, BMI research

• Industries : Pathology
• Countries : World

Oman Rheumatic Heart Disease, Total, Male, Dalys

• $ 250
• Industry data
• May 2013

Yearly, From 2005 To 2030
By Business Monitor International
Source: WHO, World Bank, IMF, BMI research

• Industries : Pathology
• Countries : Oman, World

Iran Rheumatic Heart Disease, Total, Male, Dalys

• $ 250
• Industry data
• May 2013

Yearly, From 2005 To 2030
By Business Monitor International
Source: WHO, World Bank, IMF, BMI research

• Industries : Pathology
• Countries : Iran, World

Mali Rheumatic Heart Disease, Total, Male, Dalys

• $ 250
• Industry data
• May 2013

Yearly, From 2005 To 2030
By Business Monitor International
Source: WHO, World Bank, IMF, BMI research

• Industries : Pathology
• Countries : Mali, World

Pathology in World

Palau Post-traumatic Stress Disorder, 45-59 Yrs, Male, Dalys

• $ 250
• Industry data
• May 2013

Yearly, From 2005 To 2030
By Business Monitor International
Source: WHO, World Bank, IMF, BMI research

• Industries : Pathology
• Countries : World

Iraq Prostate Cancer, 45-59 Yrs, Male, Dalys

• $ 250
• Industry data
• May 2013

Yearly, From 2005 To 2030
By Business Monitor International
Source: WHO, World Bank, IMF, BMI research

• Industries : Pathology
• Countries : Iraq, World

Cote D`ivoire Post-traumatic Stress Disorder, 45-59 Yrs, Male, Dalys

• $ 250
• Industry data
• May 2013

Yearly, From 2005 To 2030
By Business Monitor International
Source: WHO, World Bank, IMF, BMI research

• Industries : Pathology
• Countries : World

Congo-brazzaville Peptic Ulcer Disease, 45-59 Yrs, Male, Dalys

• $ 250
• Industry data
• May 2013

Yearly, From 2005 To 2030
By Business Monitor International
Source: WHO, World Bank, IMF, BMI research

• Industries : Pathology
• Countries : World

Mali Post-traumatic Stress Disorder, 45-59 Yrs, Male, Dalys

• $ 250
• Industry data
• May 2013

Yearly, From 2005 To 2030
By Business Monitor International
Source: WHO, World Bank, IMF, BMI research

• Industries : Pathology
• Countries : Mali, World